Genes to therapy: a comprehensive literature review of whole-exome sequencing in neurology and neurosurgery
Open Access
- 10 November 2024
- journal article
- research article
- Published by Springer Nature in European Journal of Medical Research
- Vol. 29 (1) , 1-26
Abstract
Whole-exome sequencing (WES), a ground-breaking technology, has emerged as a linchpin in neurology and neurosurgery, offering a comprehensive elucidation of the genetic landscape of various neurological disorders. This transformative methodology concentrates on the exonic portions of DNA, which constitute approximately 1% of the human genome, thus facilitating an expedited and efficient sequencing process. WES has been instrumental in advancing our understanding of neurodegenerative diseases, neuro-oncology, cerebrovascular disorders, and epilepsy by revealing rare variants and novel mutations and providing intricate insights into their genetic complexities. This has been achieved while maintaining a substantial diagnostic yield, thereby offering novel perspectives on the pathophysiology and personalized management of these conditions. The utilization of WES boasts several advantages over alternative genetic sequencing methodologies, including cost-effectiveness, reduced incidental findings, simplified analysis and interpretation process, and reduced computational demands. However, despite its benefits, there are challenges, such as the interpretation of variants of unknown significance, cost considerations, and limited accessibility in resource-constrained settings. Additionally, ethical, legal, and social concerns are raised, particularly in the context of incidental findings and patient consent. As we look to the future, the integration of WES with other omics-based approaches could help revolutionize the field of personalized medicine through its implications in predictive models and the development of targeted therapeutic strategies, marking a significant stride toward more effective and clinically oriented solutions. Graphical AbstractKeywords
This publication has 136 references indexed in Scilit:
- Whole exome sequencing identifies potential candidate genes for spina bifida derived from mouse modelsAmerican Journal of Medical Genetics Part A, 2022
- Mutations in KIF7 implicated in idiopathic scoliosis in humans and axial curvatures in zebrafishHuman Mutation, 2020
- Whole‐exome sequencing in 20,197 persons for rare variants in Alzheimer's diseaseAnnals of Clinical and Translational Neurology, 2018
- Whole exome sequencing identifies the first STRADA point mutation in a patient with polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome (PMSE)American Journal of Medical Genetics Part A, 2016
- dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVsHuman Mutation, 2015
- Rare and Coding Region Genetic Variants Associated With Risk of Ischemic StrokeJAMA Neurology, 2015
- Implementing individualized medicine into the medical practiceAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2014
- Mutations in KCND3 cause spinocerebellar ataxia type 22Annals of Neurology, 2012
- Genomics really gets personal: How exome and whole genome sequencing challenge the ethical framework of human genetics researchAmerican Journal of Medical Genetics Part A, 2011
- Massively parallel sequencing of ataxia genes after array-based enrichmentHuman Mutation, 2010